Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov enrollment closed later-stage tilt small index

Vascular Parkinsonism: later-stage trial registry

A small indexed set (2 trials) with no open enrollment listed right now.

Corpus placement: #7,188 of 28,707 conditions by registered trial count.

2 US clinical trials · none currently recruiting · #7,188 of 28,707 conditions by registered trial count

Vascular Parkinsonism: 2 US clinical trials tracked, none currently recruiting.

Vascular Parkinsonism is the subject of 2 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is California Pacific Medical Center Research Institute, running 1 of these trials.

Enrollment posture brief

Registry condition vascular-parkinsonism

OPEN 0 | RECR 0% | LATE 1 | EARLY 0 | RANK #7188 | SPON 1

Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Vascular Parkinsonism (this)0%
Open-enrollment share among volume-matched conditions near Vascular Parkinsonism

Vascular Parkinsonism has no open enrollment in this registry pull (2 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Vascular Parkinsonism on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Vascular Parkinsonism is recruiting below its size-band peers.

    0 of 2 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 41

Phase Distribution

PhaseTrial count
Phase 4 1

Named interventions

Most-linked intervention names on Vascular Parkinsonism records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Zoledronic Acid 5Mg/Bag 100Ml Inj Drug
1 trials
Online Community-Supported Palliative Care Other
1 trials
Parkinson Disease Standard Care Other
1 trials
Placebo Other
1 trials

US sites by state

Facility locations filed on Vascular Parkinsonism trials. A trial with sites in several states counts in each.

New York 1 trials
Connecticut 1 trials
Colorado 1 trials
California 1 trials
Arizona 1 trials
Arkansas 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Vascular Parkinsonism page

2 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Vascular Parkinsonism condition card totals 2 registered trials; most-linked intervention Zoledronic Acid 5Mg/Bag 100Ml Inj; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.